Figure 2.

Plasma concentrations of CXCL8 [interleukin-8 (IL-8)] and CCL11 (eotaxin-1) in abstinent alcohol use disorders patients with liver and/or pancreas diseases. (A) CXCL8 (IL-8) concentrations according to “liver and pancreas diseases”; (B) CXCL8 (IL-8) concentrations according to “liver and pancreas diseases” and “sex”; (C) CCL11 (eotaxin-1) concentrations according to “liver and pancreas diseases”; and (D) CCL11 (eotaxin-1) concentrations according to “liver and pancreas diseases” and “sex.” Bars are estimated marginal means and 95% CI (picograms per milliliter). Data were analyzed by two-way analysis of covariance and **p < 0.01 and ***p < 0.001 denote significant main effect of “sex” and “liver and pancreas diseases,” respectively. ⁺p < 0.05 denotes significant differences compared to female patients with no diseases because there was an interaction of factors.